Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Peanut butter fingerprints

Stanford researchers trace peanut allergy therapy's 'fingerprints'

Stanford University School of Medicine's Sean N. Parker Center for Allergy and Asthma Research was launched last year to aggressively pursue treatments with long-term benefits for severe allergies. Now, a team at the center has employed a microfluidic technology to monitor patients during immunotherapy, and shown that the approach identified

Read the full 507 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE